Veru
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.About VERU
Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin.
VERU Key Statistics
Stock Snapshot
With a market cap of 49.92M, Veru(VERU) trades at $3.00. The stock has a price-to-earnings ratio of -3.84.
As of 2026-06-09, Veru(VERU) stock has fluctuated between $2.83 and $3.42. The current price stands at $3.00, placing the stock +6.0% above today's low and -12.3% off the high.
The Veru(VERU)'s current trading volume is 2.37M, compared to an average daily volume of 10.91M.
During the past year, Veru(VERU) stock moved between $2.05 at its lowest and $7.40 at its peak.
During the past year, Veru(VERU) stock moved between $2.05 at its lowest and $7.40 at its peak.
VERU News
Novo Nordisk (NYSE:NVO) has entered a clinical supply agreement with Veru Inc. to provide Wegovy for a pivotal Phase 2b obesity trial in older adults. The agre...
In the last week, the market has stayed flat, but it is up 26% over the past year with earnings forecast to grow by 16% annually. Investing in penny stocks — th...
Canaccord keeps a Buy rating on Veru (VERU) with a $25 price target after the company disclosed a supply agreement with Novo Nordisk (NVO) for Wegovy. The news...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.